Search Page

1

Cite

Share

Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.

Brody SR, Humphreys MH, Gambertoglio JG, Schoenfeld P, Cundy KC, Aweeka FT. Brody SR, et al. Among authors: cundy kc. Clin Pharmacol Ther. 1999 Jan;65(1):21-8. doi: 10.1016/S0009-9236(99)70118-9. Clin Pharmacol Ther. 1999. PMID: 9951427

Cite

Share

2

Cite

Share

Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.

Cundy KC. Cundy KC. Clin Pharmacokinet. 1999 Feb;36(2):127-43. doi: 10.2165/00003088-199936020-00004. Clin Pharmacokinet. 1999. PMID: 10092959 Review.

Cite

Share

3

Cite

Share

Population pharmacokinetics and pharmacodynamics of gabapentin after administration of gabapentin enacarbil.

Lal R, Sukbuntherng J, Luo W, Tovera J, Lassauzet ML, Cundy KC. Lal R, et al. Among authors: cundy kc. J Clin Pharmacol. 2013 Jan;53(1):29-40. doi: 10.1177/0091270012439209. Epub 2013 Jan 24. J Clin Pharmacol. 2013. PMID: 23400741 Clinical Trial.

Cite

Share

4

Cite

Share

Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease.

LeWitt PA, Huff FJ, Hauser RA, Chen D, Lissin D, Zomorodi K, Cundy KC. LeWitt PA, et al. Among authors: cundy kc. Mov Disord. 2014 Jan;29(1):75-82. doi: 10.1002/mds.25742. Epub 2013 Dec 13. Mov Disord. 2014. PMID: 24339234 Clinical Trial.

Cite

Share

5

Cite

Share

Randomised clinical trial: arbaclofen placarbil in gastro-oesophageal reflux disease--insights into study design for transient lower sphincter relaxation inhibitors.

Vakil NB, Huff FJ, Cundy KC. Vakil NB, et al. Among authors: cundy kc. Aliment Pharmacol Ther. 2013 Jul;38(2):107-17. doi: 10.1111/apt.12363. Epub 2013 May 30. Aliment Pharmacol Ther. 2013. PMID: 23721547 Free article. Clinical Trial.

Cite

Share

6

Cite

Share

A phase I, single-dose study of the disposition of 14C-radiolabeled gabapentin enacarbil in healthy male volunteers.

Lal R, Sukbuntherng J, Ho J, Cundy KC. Lal R, et al. Among authors: cundy kc. Int J Clin Pharmacol Ther. 2011 Feb;49(2):109-15. doi: 10.5414/cpp49109. Int J Clin Pharmacol Ther. 2011. PMID: 21255527 Clinical Trial.

Cite

Share

7

Cite

Share

Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin.

Cundy KC, Sastry S, Luo W, Zou J, Moors TL, Canafax DM. Cundy KC, et al. J Clin Pharmacol. 2008 Dec;48(12):1378-88. doi: 10.1177/0091270008322909. Epub 2008 Sep 30. J Clin Pharmacol. 2008. PMID: 18827074 Clinical Trial.

Cite

Share

8

Cite

Share

A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome.

Lal R, Ellenbogen A, Chen D, Zomorodi K, Atluri H, Luo W, Tovera J, Hurt J, Bonzo D, Lassauzet ML, Vu A, Cundy KC. Lal R, et al. Among authors: cundy kc. Clin Neuropharmacol. 2012 Jul-Aug;35(4):165-73. doi: 10.1097/WNF.0b013e318259eac8. Clin Neuropharmacol. 2012. PMID: 22664749 Clinical Trial.

Cite

Share

9

Cite

Share

Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin.

Backonja MM, Canafax DM, Cundy KC. Backonja MM, et al. Among authors: cundy kc. Pain Med. 2011 Jul;12(7):1098-108. doi: 10.1111/j.1526-4637.2011.01139.x. Epub 2011 May 31. Pain Med. 2011. PMID: 21627766 Clinical Trial.

Cite

Share

10

Cite

Share

Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine.

Lal R, Sukbuntherng J, Luo W, Vicente V, Blumenthal R, Ho J, Cundy KC. Lal R, et al. Among authors: cundy kc. Br J Clin Pharmacol. 2010 May;69(5):498-507. doi: 10.1111/j.1365-2125.2010.03616.x. Br J Clin Pharmacol. 2010. PMID: 20573085 Free PMC article.

Cite

Share